Expertise in
5
conditions

Xianling H. Liu

139 Middle Renmin Road, 
Changsha, CN 
Expertise in
5
conditions
139 Middle Renmin Road, 
Changsha, CN 

Overview

Xianling Liu practices practicing medicine in Changsha, China.

Liu is highly rated in 5 conditions, according to our data. Their clinical expertise encompasses Nasopharyngeal Carcinoma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and Tissue Biopsy.

They are actively involved in clinical research, co-authoring 97 peer reviewed articles and participating in 2 clinical trials.

Locations

139 Middle Renmin Road, Changsha, 410011, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Open-label, Exploratory Phase II Clinical Study to Evaluate the Safety and Tolerability and Preliminary Efficacy of TJ107 Combine With Pembrolizumab Injection in Patients With Locally Advanced or Metastatic Solid Tumors
A Multicenter, Open-label, Exploratory Phase II Clinical Study to Evaluate the Safety and Tolerability and Preliminary Efficacy of TJ107 Combine With Pembrolizumab Injection in Patients With Locally Advanced or Metastatic Solid Tumors
Enrollment Status: Unknown
Publish Date: April 15, 2024
Intervention Type: Biological
Study Drugs: TJ107, Pembrolizumab
Study Phase: Phase 2
A Multi-center, Single Arm , Phase II Study of Atezolizumab Combined With Concurrent Chemoradiotherapy and Maintenance Therapy With Atezolizumab in Untreated Participants With Extensive-stage Small Cell Lung Cancer
A Multi-center, Single Arm , Phase II Study of Atezolizumab Combined With Concurrent Chemoradiotherapy and Maintenance Therapy With Atezolizumab in Untreated Participants With Extensive-stage Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: June 14, 2022
Intervention Type: Procedure
Study Phase: Phase 2
View 1 Less Clinical Trial

97 Total Publications

DNA hypomethylation identifying clinical benefit subgroup of small-cell lung cancer: multi-omics analysis of a phase II trial with durvalumab plus olaparib as maintenance therapy.
DNA hypomethylation identifying clinical benefit subgroup of small-cell lung cancer: multi-omics analysis of a phase II trial with durvalumab plus olaparib as maintenance therapy.
Journal: Journal for immunotherapy of cancer
Published: August 05, 2026

Frequently Asked Questions about Xianling H. Liu

Is Xianling H. Liu a top-rated expert for Nasopharyngeal Carcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Xianling H. Liu is classified as an Advanced expert for Nasopharyngeal Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Xianling H. Liu participate in research or clinical trials?

Yes. Xianling H. Liu has published 97 articles and abstracts on conditions like Nasopharyngeal Carcinoma. You can view a list of Xianling H. Liu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Liu's expertise for a condition
ConditionClose
      View All 15 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile